Your browser doesn't support javascript.
loading
Late Onset Macular Oedema in a Patient with Multiple Sclerosis Treated with Fingolimod.
Camós-Carreras, Anna; Alba-Arbalat, Salut; Dotti-Boada, Marina; Parrado-Carrillo, Alba; Bernal-Morales, Carolina; Saiz, Albert; Sánchez-Dalmau, Bernardo.
Afiliação
  • Camós-Carreras A; Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Alba-Arbalat S; Neurology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Dotti-Boada M; Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Parrado-Carrillo A; Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Bernal-Morales C; Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Saiz A; Neurology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Sánchez-Dalmau B; Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
Neuroophthalmology ; 45(1): 61-64, 2021.
Article em En | MEDLINE | ID: mdl-33762792
ABSTRACT
Macular oedema is a rare complication of fingolimod treatment. It usually presents within 3-4 months, but occasionally presents later. It can resolve without treatment despite continuation of fingolimod treatment. Herein we report a case of very late onset macular oedema in a 49-year-old woman with multiple sclerosis treated with fingolimod for 7 years. The patient presented with blurred vision in both eyes with visual acuities of 20/32 in her right eye and 20/25 in her left eye. She had macular oedema, that without discontinuing fingolimod treatment, resolved after 1 month.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article